Platform-Driven Drug Discovery & Asset Prioritization

About DarwinHealth

DarwinHealth is a privately held, New York-based biotechnology company founded in 2015, operating at the intersection of diagnostics, drug discovery, and precision oncology. Its core intellectual property is a proprietary computational platform, leveraging systems biology and its 'Oncotecture' framework, to elucidate tumor master regulators and actionable checkpoints from patient data, thereby guiding therapeutic matching and novel target identification. The company pursues a dual business model: providing diagnostic services to match patients with therapies and leveraging its platform for internal drug discovery and pharmaceutical partnerships. DarwinHealth appears to be in an early commercial or pre-revenue stage, focusing on technology validation and partnership development.

Therapeutic Areas

Other Pan-Cancer Drugs